Skip to content

Why now

  • UK 5-Year AMR National Action Plan 2024–2029
  • EU 2030 · 50% antibiotic-reduction target
  • Tier-1 retailer ESG procurement
  • The fastest-growing wine industry in Europe

The moat

  • An 11-family patent portfolio — 9 applications on file, 2 in the UKIPO Green Channel
  • Owned AI substrate — a tiered, model-agnostic architecture on owned GPUs, sub-2s and cost-controlled, with no single-vendor lock-in
  • A verified-provenance rail beneath every product, with Outcome Paper™ on top
  • A quality system aligned to ISO 9001 / 13485 / 27001 + IEC 62304 — the disciplines that govern medical devices

“A disciplined, IP-defensible platform in a market the regulators are forcing to change.”

Request the investor briefing

The detail lives behind a handshake.

Tell us a little about you and we’ll be in touch. The full pack — including financials and terms — is shared with qualified investors under a mutual NDA.

EIS-qualifying (HMRC Advance Assurance in progress). We don’t publish raise, valuation or equity terms here.

Or email investor@agroinsightsai.com directly. We aim to respond within 3–5 business days.